Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis for endometriosis pain
ACTRN12622001560785Phase 3Completed
- Sponsor
- Deakin University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol and dronabinol in endometriosis (3 arms), sponsored by Deakin University. Primary endpoints: Recruitment rate, Retention and 1 more. Started Aug 2023; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
endometriosis
Beyond the preview
Go deeper on ACTRN12622001560785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001560785.